Long-term follow-up for Huntington's disease transplant patients
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study follows up with people who received a cell transplant for Huntington's disease as part of the MIG-HD trial. It aims to see how they are doing in the long term, which may help future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the MIG-HD study, which tested a cell transplant for Huntington's disease
- You are 18 years old or older
- You (or your legal representative) are willing to give informed consent
- You are not currently pregnant or breastfeeding
- You are not receiving government emergency medical aid (AME)
- You must be able to express your consent (or have legal protection in place)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special brain imaging and memory/thinking tests to find early “markers” that can predict how Huntington’s disease will progress over time. You may qualify as someone with early-stage Huntington’s or as a healthy control, if you meet specific safety and scoring requirements.
This study follows people with Huntington's disease (or those who carry the gene) over time using online surveys. It aims to better understand how the disease progresses, which could help improve future care.
This study is building a biobank to better understand Huntington's disease by using remote monitoring and deep phenotyping (collecting detailed health information). It may help develop better ways to track the disease and improve care for people with the Huntington's gene expansion.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study tracks people with sickle cell disease or thalassemia who have had a bone marrow transplant or gene therapy in the past 15 years. It aims to monitor their health over time to understand long-term effects.
This study follows people who are at least 3 years out from their first stem cell transplant to learn how they are doing long term. It may help improve future transplant care by tracking outcomes over time.
Hear when a new Huntington Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.